Comply with Us: Improving Medication Adherence

Journal of Pharmacy Practice

Volumn 17, Issue 3, 2004, Pages 167-181

  Tabor, Patricia A ^a,b,c   Lopez, Debra A ^d,e  

^a Hlth Plan/Clin ^*  (United States)

^b Division of Urology   (United States)

^c Scott and White Clinic   (United States)

^d Blackstock Fam Pract Acad Assoc   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Adherence; Drug therapy; Nonadherence; Noncompliance; Patient compliance

Indexed keywords

BEHAVIOR MODIFICATION; HEALTH BEHAVIOR; HEALTH CARE UTILIZATION; HUMAN; OUTCOMES RESEARCH; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACIST; REVIEW;

EID: 2442493985     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/0897190004264816     Document Type: Review

References (117)

1. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: Johns Hopkins University Press; 1979.
2. Sackett DL, Snow JC. The magnitude of compliance and noncompliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: Johns Hopkins University Press; 1979:11-22.
3. Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis. 1993;147(5):1311-1320.
4. Becker MH. Patient adherence to prescribed therapies. Med Care. 1985;23(5):539-555.
5. Tafreshi MJ, Melby MJ, Kaback KR, et al. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother. 1999;33:1252-1257.
6. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy. 2002;22(7):915-923.
7. Sullivan SD, Kreling DH, Hazlet TK. Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. J Res Pharm Econ. 1990;2(2):19-33.
8. Berg JS, Dischler J, Wagner DJ, et al. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27(9):S3-S19.
9. Sackett DL, Haynes RB, eds. Compliance With Therapeutic Regimens. Baltimore, Md: Johns Hopkins University Press; 1976.
10. Donovan JL, Blake DR. Patient non-compliance-deviance or reasoned decision-making? Soc Sci Med. 1992;34(5):507-513.
11. Prescription medicine compliance: a review of the baseline of knowledge. Presented at: Conference Advancing Prescription Medicine Compliance: New Paradigms, New Practices; December 1994; Washington, DC.
12. Garcia PR, Cote JK. Factors affecting adherence to antiretroviral therapy in people living with HIV/AIDS. J Assoc Nurses AIDS Care. 2003;14(4):37-45.
13. Miller NH, Hill M, Kottke T, et al. For the American Heart Association Expert Panel on Compliance. The multilevel compliance challenge: recommendations for a call to action - a statement for healthcare professionals. Circulation. 1997;95(4):1085-1090.
14. Urquhart J, Chevalley C. Impact of unrecognized dosing errors on the cost and effectiveness of pharmaceuticals. Drug Inf J 1988;22:363-378.
15. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol. 1986;77(1):65-70.
16. Levy RA. Failure to refill prescriptions: incidence, reasons and remedies. In: Cramer JA, Spilder B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York, NY: Raven; 1991;11-18.
17. American Association of Retired Persons. Prescription Drugs: A Survey of Consumer Use, Attitudes and Behaviors. Washington, DC: American Association of Retired Persons; 1994.
18. Maronde RF, Chan LS, Larsen FJ, et al. Underutilization of antihypertensive drugs and associated hospitalization. Med Care. 1989;27(12):1159-1166.
19. Jones JG. Compliance with pediatric therapy: a selective review and recommendations. Clin Pediatr (Phila). 1983;22(4):262-265.
20. Christensen DB, Campbell WH, Madsen S, et al. Documenting outpatient problem intervention activities of pharmacist in an HMO. Med Care. 1981;19(1):104-117.
21. Glasgow RE, McCaul KD, Schafer LC. Self-care behaviors and glycemic control in type 1 diabetes. J Chronic Dis. 1987;40(5):399-412.
22. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med. 1985;20(1):29-37.
23. Bush PJ, Spector KK, Rabin DL. Use of sedatives and hypnotics prescribed in a family practice. South Med J. 1984;77(6):677-681.
24. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074-1090.
25. Nides MA, Tashkin DP, Simmons MS, et al. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest. 1993;104(2):501-507.
26. Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest. 2002;121(3):871-876.
27. Bender BG, Wamboldt FS, O'Connor SL, et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and doser CT. Ann Allergy Asthma Immunol. 2000;85:416-421.
28. Dunbar-Jacob J, Bohachick P, Mortimer MI, et al. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs. 2003;18(3):209-218.
29. McNabb JJ, Nicolau DP, Stoner JA, et al. Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS. 2003;17(12):1763-1767.
30. Dusing R, Lottermoser K, Mengden T. Compliance with drug therapy - new answers to an old question. Nephrol Dial Transplant. 2001;16:1317-1321.
31. Poirier S, Jackson RA, Perri M, et al. Compliance enhancement: all have a stand, all stand to gain. Am Pharm. 1999;June:31-42.
32. Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc (Wash). 2000;40(4):475-485.
33. Cramer JA. Relationship between medication compliance and medical outcomes. Am J Health Syst Pharm. 1995;52(suppl 3):S27-S29.
34. Fincham JE, Wertheimer AI. Using the health belief model to predict initial drug therapy defaulting. Soc Sci Med. 1985;20(1):101-105.
35. Perkins DO. Adherence to antipsychotic medications. J Clin Psychiatry. 1999;60(suppl 21):25-30.
36. Rotter JB. Generalized expectancies for internal locus of control of reinforcement. Monograph no. 609. Psychol Monogr. 1966;80.
37. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am Psychol. 1992;47(9):1102-1114.
38. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38-48.
39. Berger BA, Hudmon KS. Readiness for change: implications for patient care. J Am Pharm Assoc (Wash). 1997;NS37(3):321-329.
40. Dombrowski SR, Ferro LA. Pharmacist counseling on nutrition and physical activity - part 2 of 2: helping patients make changes. J Am Pharm Assoc (Wash). 1999;39(5):613-627.
41. Strategies to Improve Patient Compliance. Wilmington, Del: Zeneca Pharmaceuticals; 1999.
42. Dezii CM. Medication noncompliance: what is the problem? Manag Care. 2000;9(suppl 9):7-12.
43. Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol. 2002;109(6):S554-S559.
44. Gottlieb H. Medication nonadherence: finding solutions to a costly medical problem. Drug Benefit Trends. 2000;12(6):57-62.
45. Joyce CR, Caple G, Mason M, et al. Quantitative study of doctor-patient communication. Q J Med. 1969;38(150):183-194.
46. Gibbs RD, Gibbs PH, Henrich J. Patient understanding of commonly used medical vocabulary. J Fam Pract. 1987;25(2):176-178.
47. LaPierre G, Mallet L. Readability of materials. Can Pharm J. 1987;120:718-728.
48. Murphy J, Coster G. Issues in patient compliance. Drugs. 1997;54(6):797-800.
49. National Asthma Education and Prevention Program Expert Panel. Guidelines for the Diagnosis and Management of Asthma - Update on Selected Topics 2002. NIH publication no. 02-5075. Bethesda, Md: National Institutes of Health; 1995.
50. Pharmacist-Patient Consultation Program PPCP-unit 3: counseling to enhance compliance. New York, NY: Pfizer Inc; 1995.
51. Moitabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003;22(4):220-229.
52. Mayeaux EJ Jr, Murphy PW, Arnold C, et al. Improving patient education for patients with low literacy skills. Am Fam Physician. 1996;53(1):205-211.
53. National Center for Education Statistics. Adult Literacy in America: A First Look at the Findings of the National Adult Literacy Survey. Washington, DC: US Department of Education; 1993.
54. Andrus MR, Roth MT. Health literacy: a review. Pharmacotherapy. 2002;22(3):282-302.
55. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.
56. Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892-909.
57. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol. 1997;79:177-187.
58. Tettersell MJ. Asthma patients' knowledge in relation to compliance with drug therapy. J Adv Nurs. 1993;18:103-113.
59. Patel RP, Taylor SD. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother. 2002;36:40-45.
60. Fogarty L, Roter D, Larson S, et al. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46(2):93-108.
61. Malcolm SE, Ng JJ, Rosen RK, et al. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care. 2003;15(2):251-261.
62. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33:1336-1355.
63. Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacists' clinical services. Am J Health Syst Pharm. 2001;58:569-577.
64. Newell SA, Bowman JA, Cockburn JD. A critical review of interventions to increase compliance with medication-taking, obtaining medication refills, and appointment-keeping in the treatment of cardiovascular disease. Prev Med. 1999;29:535-548.
65. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868-2879.
66. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348(9024):383-386.
67. Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care. 2000;9(suppl 9):2-6.
68. Sclar DA, Skaer TL, Chin A, et al. Effectiveness of the C Cap™ in promoting prescription refill compliance among patients with glaucoma. Clin Ther. 1991;13(3):396-400.
69. Murray MD, Birt JA, Manatunga AK, et al. Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacother. 1993;27:616-621.
70. Rehder TL, McCoy LK, Blackwell B, et al. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm. 1980;37(3):379-385.
71. Dolder CR, Lacro JP, Leckband S, et al. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol. 2003;23(4):389-399.
72. Cole P, Emmanuel S. Drug consultation: its significance to the discharged hospital patient and its relevance as a role for the pharmacist. Am J Hosp Pharm. 1971;28:955-960.
73. Lipton HL, Bird JA. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34(3):307-315.
74. De Tullio PL, Kirking DM, Arslanian C, et al. Compliance measure development and assessment of theophylline therapy in ambulatory patients. J Clin Pharm Ther. 1987;12(1):19-26.
75. Sclar DA, Chin A, Skaer TL, et al. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther. 1991;13(4):489-495.
76. De Tullio PL, Corson ME. Effect of pharmacist counseling on ambulatory patients' use of aerosolized bronchodilators. Am J Hosp Pharm. 1987;44(8):1802-1806.
77. Garnett WR, Davis LJ, McKenney JM, et al. Effect of telephone follow-up on medication compliance. Am J Hosp Pharm. 1981;38:676-679.
78. Cegala DJ, Marinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med. 2000;9:57-64.
79. McKenney JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973;48:1104-1111.
80. Park JJ, Kelly P, Carter BL, et al. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash). 1996;NS36(7):443-451.
81. Sczupak CA, Conrad WF. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm. 1977;34:1238-1242.
82. Kelly GR, Scott JE, Mamon J. Medication compliance and health education among outpatients with chronic mental disorders. Med Care. 1990; 28(12):1181-1197.
83. Raynor DK, Booth TG, Blenkinsopp A. Effects of computer generated reminder charts on patients' compliance with drug regimens. BMJ. 1993;306(6886):1158-1161.
84. Lin EHB, Von Korff M, Ludman EJ, et al. Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry. 2003;25:303-310.
85. Hogarty GE, Anderson CM, Reiss DJ, et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia: II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizophrenia (EPICS) Research Group. Arch Gen Psychiatry. 1991;48(4):340-347.
86. Eckman TA, Liberman RP, Phipps CC, et al. Teaching medication management skills to schizophrenic patients. J Clin Psychopharmacol. 1990;10(1):33-38.
87. Hornung WP, Kieserg A, Feldmann R, et al. Psychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns. 1996;29(3):257-268.
88. Ayd FJ Jr. Rational pharmacotherapy: once-a-day drug dosage. Dis Nerv Syst. 1973;34(7):371-378.
89. Farmer KC, Jacobs EW, Phillips CR. Long-term patient compliance with prescribed regimens of calcium channel blockers. Clin Ther. 1994;16(2):316-326.
90. McKenney JM. The clinical pharmacy and compliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: Johns Hopkins University Press; 1979:260-277.
91. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880-2883.
92. Stephenson BJ, Rowe BH, Haynes RB, et al. Is this patient taking the treatment as prescribed? JAMA. 1993;269(21):2779-2781.
93. Mushlin AI, Appel FA. Diagnosing potential noncompliance: physicians' ability in a behavioral dimension of medical care. Arch Intern Med. 1997;137(3):318-321,
94. Stewart M. The validity of an interview to assess a patient's drug taking. Am J Prev Med 1987;3(2):95-100.
95. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
96. Svarstad BL, Chewning BA, Sleath BL, et al. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113-124.
97. Raehl CL, Bond CA, Woods T, et al. Individualized drug use assessment in the elderly. Pharmacotherapy 2002;22(10):1239-1248.
98. Meyer ME, Schuna AA. Assessment of geriatric patients' functional ability to take medication. Drug Intell Clin Pharm. 1989;23:171-174.
99. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998; 279(18):1458-1462.
100. Markowitz M. Eradication of rheumatic fever: an unfulfilled hope. Circulation. 1970;41(6):1077-1084.
101. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992;102(2):493-496.
102. Felkey BG. Adherence screening and monitoring. Am Pharm. 1995;NS35(7):42-51.
103. Landis NT. Lessons from medicine and nursing for pharmacist-patient communication. Am J Health Syst Pharm. 1996;53:1306-1314.
104. Pharmacist-patient consultation program: an interactive approach to verify patient understanding. New York, NY: Pfizer, Inc; 1991.
105. Pharmacist-patient consultation program PPCP-unit 2: how to counsel patients in challenging situations. New York, NY: Pfizer, Inc; 1993.
106. Davis TC, Michielutte R, Askov EN, et al. Practical assessment of adult literacy in health care. Health Educ Behav. 1998;25(5):613-624.
107. Nichols-English G. Improving health literacy: a key to better patient outcomes. J Am Pharm Assoc (Wash). 2000;40(6):835-836.
108. National Asthma Education and Prevention Program Expert Panel. Component 4: education for a partnership in asthma care. In: Clinical Practice Guidelines: Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health, National Heart, Lung and Blood Institute; 1997:123-144.
109. Hsaio LD, Salmon JW. Predicting adherence to prescription medication purchase among HMO enrollees with diabetes. Managed Care Pharm. 1999;5(4):336-341,
110. Abel E, Painter L. Factors that influence adherence to HIV medications: perceptions of women and health care providers. J Assoc Nurses AIDS Care. 2003;14(4):61-69.
111. Lyon ME, Trexler C, Akpan-Townsend C, et al. A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project. AIDS Patient Care STDS. 2003;17(6):299-308.
112. Roter DA, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-1161.
113. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811.
114. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes: a critical review. Arch Intern Med. 1997;157(17):1921-1929.
115. Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther. 1993;15(6):1121-1132.
116. Cody M, McCombs JS, Parker JP. The Kaiser Permanente/USC patient consultation study: change in quality of life. Am J Health Syst Pharm. 1998;55:2615-2620.
117. McCombs JS, Liu G, Shi J. et al. The Kaiser Permanente/USC patient consultation study: change in use and cost of health care services. Am J Health Syst Pharm. 1998;55:2485-2499.